# Evidence E: Weeks 1–4 on tirzepatide (after the first fill, before the second)

Scope: the patient has completed the GLP-1 evaluation and the first fill has been transmitted/dispensed.
This file covers day 0 through the week-4 dose-escalation decision: medication onboarding, care plan and
next steps, scheduled medication check-ins, side-effect reporting and escalation, care-team messaging,
General AI, notifications, refill timing for a 4-dose/28-day box, re-prescribing and PA renewal, month-1
billing, cancellation/pausing, adherence tracking, and weight/vitals capture.

Method: re-read the recovered first-party app (`app/`, `lib/store/api/*`, `lib/*`, `components/*`,
`contexts/`, `hooks/`, `packages/`, `types/`) and the four internal-portal operation inventories; re-fetched
public `generalmedicine.co` pages, public `/api/external/*` GETs, the Zepbound label, and LillyDirect pricing
on **2026-10-19**. Read-only GETs only; no account, form, checkout, or personal data.

Tag legend: `[CODE path:line]`, `[LIVE url, 2026-10-19]`, `[DATA file → key]`, `[DOC file §section]`,
`[PUBLIC url]`, `[INFERENCE]`.

**Recovery caveat that bounds this file.** The recovered tree contains the account *data layer* and flow
helpers but not the authenticated account page components (`app/account/**`, `app/prescriptions/**`,
`components/Prescriptions/*` beyond `criteriaNavigation.ts`) and not `types/interfaces/*`. The check-in
routes, API contracts, state machines and copy are therefore observed; the exact rendered page layout and
the questionnaire text are not. The live account routes return `307 → /login` (checked 2026-10-19), so no
authenticated screen could be observed without creating an account. Every place this matters is marked
`[INFERENCE]` or listed in §6.

---

## 0. The loop in one paragraph (what GM actually built)

GM does not run a subscription. It runs a **visit-fee + dispense-fee + scheduled-criteria** loop. A clinician
signs an encounter, a `Care::Plan` is generated/curated and sent, the prescription becomes a `PharmacyOrder`
that the patient must route to a pharmacy and pay for (or adjudicate), and the patient then self-injects
weekly with no GM instrumentation. GM's only recurring levers are (a) the **Updates/Next Steps** feed,
(b) the **medication check-in** (questionnaire + optional lab bundle) that is attached to the prescription's
renewal criteria, (c) **care-team messaging / SMS**, and (d) the **General AI** copilot. The week-4
dose-escalation decision is a clinician action (`changePhase` / `batchChangePatientMedicationPhases`) that
produces a *new* prescription for a *new* strength, which is a *new* pharmacy order and may be a *new* PA —
not a modification of the existing fill.

---

## 1. Steps table

**Clock definition.** D0 is the **first self-administered dose**, not the first click. On a same-day cash
path (LillyDirect/Amazon or retail pickup) D0 is usually the visit day; on an insured/PA path the fill can
lag the visit by several business days. The click → visit → fill → first-dose offsets are **not measured**
and are left Unknown; acquisition/intake timing belongs to evidence files A–D. Week numbers are days after the first
dose.

| step | day/time | patient sees / does | GM system / screen / route | data captured or emitted | evidence |
|---|---|---|---|---|---|
| **E1** | D0, before first dose (same-day path) | Sees the care plan land in the account: a plan with “next steps”, a “why this” rationale, and a prescription card. | `Care::Plan` lifecycle; `/account`, `/account/care-plans`, `/account/next-steps`. `GET /api/external/dashboard/show`, `GET /api/external/cares/{careId}`, `GET /api/external/next_steps/by_care/{careId}`, `GET /api/external/dashboard/next_step_cards`. Plan copy: `remainingMessage`, `caughtUpMessage`, `followUpAction: "Schedule visit"`, `labsTitle: "Book {count} {noun}"`, `bookLabsAction: "Book labs"`. | `care_id`, `plan_id`, `state` (observed values include `awaiting_curation`, `awaiting_external_work`, `awaiting_generation`, `awaiting_first_send`, `awaiting_curation_send`, `in_review`, `sent`; the progression order is inferred from the names, not from an observed transition log), `provider_message`, `patient_instructions`, next-step `type/state/lab_names/scheduled_at/lab_order_id/questionnaire_id/patient_rationale`. | `[CODE lib/store/api/carePlanApi.ts:7-22,55-77]`; `[CODE lib/store/api/dashboardApi.ts:56-68]`; `[CODE lib/content/carePlan.ts:30-45]`; `[CODE components/CareActions/careActionSection.ts:37-91]`; `[DOC architecture.md §8.2]`; `[LIVE https://generalmedicine.co/p/lilly/weight-loss, 2026-10-19: “Prescriptions, lab orders, and referrals are sent right to your account”]` |
| **E1.1** | D0, before first dose | Opens the prescription card and is asked to choose a pharmacy and a payment mode. | `POST /api/external/prescriptions/{careActionPrescriptionId}/ensure_pharmacy_order` creates the order, then `GET /api/external/pharmacy_comparisons?medication_option_sku_id=…&latitude=…&longitude=…`, `POST /pharmacy_orders/{id}/select_pharmacy`, then one of `checkout`, `checkout_with_insurance`, `checkout_for_pharmacy_delegation`. | `pharmacy_order_id`, `medication_option_sku_id`, `ncpdp_provider_id`, `arrive_rtpbi_inquiry_id`, `billing_type` (`cash`/`insurance`/`pharmacy_delegation`/`gm_card`), `cash_price`, `insurance_price`, `state`. | `[CODE lib/api/endpoints.ts:236-239]`; `[CODE lib/store/api/pharmacyOrderApi.ts:26-118]`; `[DOC architecture.md §9.1]`; `[LIVE https://generalmedicine.co/api/external/pharmacy_comparisons?medication_option_sku_id=710641&latitude=37.7749&longitude=-122.4194, 2026-10-19]` |
| **E1.2** | D0, before first dose | Compares pharmacies; for a 2.5 mg Zepbound KwikPen sees LillyDirect and Amazon at $299 vs Walgreens/Costco/Safeway/Walmart at $496.12 and CVS at $508.09. | Compare drawer / pharmacy order options. Featured manufacturer-direct pharmacies pinned above retail; 2 nearby retail : 1 online interleave; Amazon forced into the first online slot. | NCPDP id, chain name, distance, `total_price_cents`, fulfillment owner (`lilly_direct`, `amazon_pharmacy`, `cvs`, `walgreens`, `walmart`, `other_pharmacy`). | `[LIVE https://generalmedicine.co/api/external/pharmacy_comparisons?medication_option_sku_id=710641&latitude=37.7749&longitude=-122.4194, 2026-10-19]`; `[CODE components/Refresh/SearchResults/searchPharmaciesUtils.ts:72-134]`; `[DOC architecture.md §9.1]` |
| **E1.3** | D0−D3 (before first dose) | Pays (cash pre-pay in-app, insurance copay at counter, or presents the GM savings card at the counter). | Stripe payment for `cash`/`gm_card`; `checkout_with_insurance` for adjudication; `checkout_for_pharmacy_delegation` for the `gm_card` path. `GET /pharmacy_orders/{id}/gm_card` returns BIN/PCN/group/member. Last fill’s card is auto-selected via `GET /prescription_orders/{orderId}/previous_fill_payment_method`. | `payment_method_id`, `return_url`, `billing_type`, `gm_card {bin,pcn,group,member_id}`, `pharmacy_submission_state`. | `[CODE lib/store/api/pharmacyOrderApi.ts:61-118]`; `[CODE lib/store/api/paymentServiceApi.ts:18-21]`; `[CODE lib/utilities.ts:949-979]`; `[LIVE https://generalmedicine.co/api/external/pharmacy_orders/{id}/gm_card is documented at openapi.yaml:1390-1420]`; `[DOC architecture.md §9.1]` |
| **E1.4** | D0 (first dose) | Gets a notification that the prescription was sent; picks up or receives the 4-dose box; takes the first injection. | No GM “first dose” screen. Notification copy promise: “You’ll get a notification as soon as it’s sent.” Delivery: retail pickup, LillyDirect/Amazon delivery, or mail. | Prescription sent event; pharmacy order state; no dose-taken event. | `[LIVE https://generalmedicine.co/faq, 2026-10-19: “You’ll get a notification as soon as it’s sent”]`; `[PUBLIC https://www.lilly.com/lillydirect/zepbound: “4 pens per monthly prescription”, delivery/pickup]`; `[INFERENCE] first-dose timing is patient-driven; no GM timestamp` |
| **E2** | D0–D1 | Learns to inject. Sources: the pharmacy label/SIG on the box, the manufacturer’s Instructions for Use, pharmacist counseling at pickup, any link/text the clinician put in `patient_instructions`, and the care team/AI if they ask. | The app ships a `formatInstructions` normalizer for pharmacy SIGs, so the prescription detail is the likely renderer (the component itself was not recovered); care-plan `patient_instructions` auto-link any http(s) URL; messaging/AI are the fallback. **No first-party injection-training module, video, or step-by-step guide exists in the recovered source.** | SIG text, `patient_instructions` (with autolinked URLs), presentation (KwikPen vs single-dose pen vs vial), needle requirement. | `[CODE lib/utilities.ts:620-660]`; `[CODE lib/autolinkText.ts:1-40]`; `[CODE components/ProductDetailPage/sharedSectionsData.ts:13-18]`; `[PUBLIC https://pi.lilly.com/us/zepbound-uspi.pdf §2.4: presentation-specific training required]`; `[PUBLIC https://www.lilly.com/lillydirect/zepbound: KwikPen “Pen needle purchase required”; single-dose pens include the needle]`; `[LIVE https://generalmedicine.co/ai, 2026-10-19: example prompt “I got prescribed a GLP-1, but I don’t know how to administer it.”]`; negative grep: no `inject`/`needle` content module in the app |
| **E3** | D1–D27 | Messages the care team or asks General AI about side effects, missed doses, food, labs, cost, or “what’s next”. | Message Center `/account/messages` (Twilio Conversations) **if the server-evaluated `message-center` flag is on**; otherwise the “Text us” action opens SMS to the tenant number. General AI at `/ai`, `/ai/chat`, `/ai/onboarding`, `/ai/health-records`. Side-effect and adjustment visits are separate SKUs. | Conversation/subject (`visit`, `lab`, `pharmacy_order`), message text, file-upload ids, `response_expectation`, AI messages, consent flags. | `[CODE lib/store/api/messageCenterApi.ts:18-108,168-270]`; `[CODE hooks/useContactSupport.ts:10,59-92]`; `[CODE contexts/AccountDashboardFeatureContext.tsx:9-28]`; `[CODE hooks/useGeneralAiStatus.tsx:166-220]`; `[LIVE https://generalmedicine.co/api/external/tenant_integrations/phone_number → {“phone_number”:“98528”}, 2026-10-19]`; `[LIVE https://generalmedicine.co/resources/using-a-glp-1-for-weight-loss, 2026-10-19: “message your care team … same-day support available during business hours”]` |
| **E4** | D7, D14, D21 | Takes doses 2, 3, 4. No GM screen, reminder, or confirmation. | None. No dose scheduler, no push, no “mark as taken”, no adherence event. | Nothing emitted. The only proxy is the eventual refill order and the check-in self-report. | `[PUBLIC https://pi.lilly.com/us/zepbound-uspi.pdf §2.1: once weekly]`; `[CODE negative: no service worker / Notification.requestPermission / pushManager / dose-log endpoint in recovered source or openapi.yaml]`; `[INFERENCE] the patient is unobserved between fills unless they initiate contact` |
| **E5** | D21–D28 (window) | Gets a refill reminder and/or sees a new check-in in Next Steps/Updates. | Refill reminder promise; `DashboardPrescription.earliest_fill_date`, `has_pending_criteria`, `criteria_deadline`; `CareJourneyGroup.available_at` + `locked` gate time-based criteria; `NextStepCard` with `deadline` and `assigned_by`. | `earliest_fill_date`, `criteria_deadline`, pending criteria count, next-step `deadline`, `snooze`/`dismiss` state. | `[CODE lib/store/api/dashboardApi.ts:27-43]`; `[CODE lib/store/api/careJourneyApi.ts:39-77]`; `[CODE lib/store/api/nextStepCardsApi.ts:16-45]`; `[LIVE https://generalmedicine.co/telehealth-informed-consent, 2026-10-19: “Prescription refill reminders (if applicable)”]`; `[LIVE https://generalmedicine.co/s/prescription-renewal/200007, 2026-10-19: “We’ll remind you when it’s time”]`; `[INFERENCE] exact offset (e.g. day 21 vs day 25) is server-side and not recovered` |
| **E6** | D~28 | Completes the medication check-in: a questionnaire, and labs if the prescription’s criteria require them (draw at Quest/Labcorp/BioReference or upload an external PDF). | `/account/medication-check-in` (hub), `/labs`, `/labs/upload`, `/progress`, `/complete`; prescription-scoped `/prescriptions/{id}/check-in`, `/questionnaire`, `/labs`, `/complete`. APIs: `GET /care_journey/next_steps`, `POST /care_journey/lab_bundle`, `POST /care_journey/complete_lab_upload`, `POST /care_journey/share_lab_upload_for_booking`, `POST /patient_medications/{id}/lab_bundle`. | `summary.actionable_count`, `estimated_minutes`, `soonest_deadline`; checklist item `type` (Lab/Questionnaire/Visit), `status`, `locked`, `deadline`, `medication_names`, `lab_bundle`, `lab_sku_ids`; questionnaire response id; `lab_order_id`; `skus[]`; `submitted_at`. | `[CODE lib/medicationCheckInLabFlow.ts:4-11,48-105]`; `[CODE lib/prescriptions/prescriptionCheckInFlow.ts:4-12,44-98]`; `[CODE lib/store/api/careJourneyApi.ts:39-77,99-180]`; `[CODE lib/store/api/prescriptionApi.ts:54-71]`; `[CODE lib/focusedFlow.ts:17-29]`; `[CODE lib/store/api/dashboardApi.ts:14: renewal-criteria questionnaires are excluded server-side from dashboard/show]`; `[LIVE https://generalmedicine.co/resources/using-a-glp-1-for-weight-loss, 2026-10-19: monthly check-ins while titrating]`; `[LIVE https://generalmedicine.co/p/lilly/weight-loss, 2026-10-19: “we’ll also reach out periodically … answer a few questions or get labs”]` |
| **E7** | D~28 | Waits for clinician review; may be asked to book a visit; is told to continue 2.5 mg, increase to 5 mg, lower the dose, or switch. | Visitron review operations include `createNextStepReview`, `generateNextStepReview` (AI draft), `updateNextStepReview`, `applyReview`, `rejectReview`, `confirmCarePlan`, `confirmNoChange` (the exact call order is inferred). Dose change: `changePhase`, `changePathway`, `batchChangePatientMedicationPhases`. | `proposed_json` → `final_json`, review decision, `patient_rationale`, new phase, new strength, visit request. | `[DATA osint/internal_portals_recon.json → visitron.rtk_endpoints]`; `[DOC architecture.md §8.2]`; `[PUBLIC https://pi.lilly.com/us/zepbound-uspi.pdf §2.1: after 4 weeks increase to 5 mg; 2.5 mg is not a maintenance dose]`; `[LIVE https://generalmedicine.co/s/weight-loss-follow-up/300550, 2026-10-19: “Discuss whether your current plan or dose is still the right fit”; “tradeoffs of increasing versus staying”]`; `[LIVE https://generalmedicine.co/api/external/product_detail_pages/710641, 2026-10-19: “increase every four weeks based on tolerance and response”]` |
| **E8** | D28–D31 | Gets a new prescription for the new strength (if escalated), re-selects the pharmacy, and pays the new price: 5 mg KwikPen $399 vs 2.5 mg $299 at LillyDirect/Amazon; retail stays ~$496–$508. | New `PharmacyOrder` for the new `medication_option_sku_id` (new strength = new SKU), new `select_pharmacy` + checkout, possibly a new PA/RTPBI. | New `pharmacy_order_id`, new `medication_option_sku_id`, new price, new PA requirement, new `arrive_rtpbi_inquiry_id`. | `[LIVE https://generalmedicine.co/api/external/medication_option_skus/710643/cash_price?zip_code=94107 → 39900, 2026-10-19]`; `[LIVE https://generalmedicine.co/api/external/pharmacy_comparisons?medication_option_sku_id=710643… → LillyDirect/Amazon $399, retail $496.12–$508.09, 2026-10-19]`; `[CODE lib/api/endpoints.ts:236-239]`; `[INFERENCE] new strength is a new NDC and commonly a new PA/step-therapy edit; no PA-submission endpoint was observed` |
| **E9** | D28+ | Orders the next 4-dose box; if on ≥7.5 mg at LillyDirect, must refill within 45 days to keep $449. | Refill = direct pharmacy order when refills remain; renewal = `NextStep::PrescriptionRenewal` when none remain. `prescription_renewal_destination` chooses `/prescriptions/renew/{nextStepId}`, `/prescriptions/renew`, or the public `200007` page. | `due_date`, `on_next_step`, `open_to_renew`, `number_of_prescriptions`, `visit_options`. | `[LIVE https://generalmedicine.co/api/external/product_detail_pages/710641 → default_days_supply 28, “28 days supply”, 2026-10-19]`; `[PUBLIC https://www.lilly.com/lillydirect/zepbound: “Month is defined as 28-days and 1 single-patient-use KwikPen”; 45-day refill window; late prices $499/$699]`; `[CODE lib/store/api/prescriptionRenewalApi.ts:5-22]`; `[CODE lib/store/api/prescriptionApi.ts:10-20]`; `[CODE hooks/usePrescriptionRenewalDestination.ts:22-30,54-66]`; `[LIVE https://generalmedicine.co/resources/medication-faqs, 2026-10-19: refill vs renewal; “most refill requests … same day”]` |
| **E10** | D28+ | Experiences the month-1 billing set: visit fee, medication cash/copay, optional labs, optional follow-up, possible cancellation fee. | Stripe / pharmacy counter / lab checkout; `GET /orders` for receipts; `GET /pharmacy_orders/{id}/invoice`. | `billing_type`, `cash_price`, `insurance_price`, `clinical_fee_cents`, `payment_method_id`, `invoice_id`. | `[LIVE https://generalmedicine.co/api/external/sku_options/300543, 2026-10-19]`; `[LIVE https://generalmedicine.co/api/external/lab_skus/503263, 2026-10-19]`; `[LIVE https://generalmedicine.co/cancellation-policy, 2026-10-19]`; `[CODE lib/store/api/patientOrdersApi.ts:7-13]`; see §4 |
| **E11** | Any time | Cancels/reschedules a visit, cancels/switches a pharmacy order, declines a renewal, or simply stops refilling. There is no “pause subscription”. | Visit cancellation by patient; `POST /pharmacy_orders/{id}/cancel {pharmacy_change}`; `POST /next_step_prescription_renewals/{id}/decline {cancellation_reason}`; `completed_elsewhere`; account closure by email to privacy@. | Cancellation reason, `can_cancel_pharmacy_order`, `can_switch_pharmacy`, `can_choose_new_pharmacy`; no subscription state. | `[LIVE https://generalmedicine.co/cancellation-policy, 2026-10-19]`; `[CODE lib/store/api/pharmacyOrderApi.ts:15-24,46-59]`; `[CODE lib/store/api/prescriptionRenewalApi.ts:159-177]`; `[LIVE https://generalmedicine.co/faq, 2026-10-19: close account via privacy@generalmedicine.co]`; `[LIVE https://generalmedicine.co/p/lilly/weight-loss, 2026-10-19: “No subscription needed”]` |
| **E12** | Continuous | Does **not** log weight, doses, or vitals in GM. Weight/waist is captured at visits; labs at the lab; adherence is inferred from refill cadence and self-report. No Withings/Fitbit/Apple Health/Google Fit/Terra/HealthKit integration exists in the recovered client. | None. `/account/labs` shows lab results; `/account/medications` shows prescriptions; no weight log. | Weight/waist only if the patient types it into a questionnaire or the clinician records it; lab biomarkers from lab orders; no device data. | `[LIVE https://generalmedicine.co/resources/using-a-glp-1-for-weight-loss, 2026-10-19: “Weight and waist size — Every visit”]`; `[CODE negative: no weight/vitals endpoint in openapi.yaml; no HealthKit/Terra/Withings/Fitbit tokens in source]`; `[CODE lib/store/api/dashboardApi.ts:27-43: only `earliest_fill_date`/`has_pending_criteria`, no adherence field]`; `[DOC adversarial-and-market-report.md §3.6: no App Store/Google Play listing]` |
| **E13** | Continuous | Uses General AI as the between-visit navigator: “I missed a dose”, “I’m having side effects”, “what do these labs mean”, “what’s next in my care plan”. | `/ai`, `/ai/onboarding` (HIPAA AI consent), `/ai/health-records` (Metriport/Particle prewarm if `gen-ai-prewarm-copilot`), `/ai/chat`. `GET/POST /copilot/messages`, `message_received`, `message_processing_locked`, `loading_indicator`, `consent/status|mark`. | Session exists/messages_count, consent, chat messages, feedback reaction/category/comment (Braintrust span). | `[CODE hooks/useGeneralAiStatus.tsx:11-12,58,166-220]`; `[CODE lib/api/endpoints.ts:309-319]`; `[CODE components/Refresh/AIPage/IdeasSection/IdeasSection.tsx:11-32]`; `[CODE lib/store/api/assistantFeedbackApi.ts:1-66]`; `[LIVE https://generalmedicine.co/ai, 2026-10-19: “trained not to offer diagnosis, medical advice”; async consult 24–48h]`; `[DOC architecture.md §10.8]` |
| **E14** | Continuous | Receives notifications: in-app Updates badge/feed, email and text for visit links and lab results, refill reminders. No push. | `/account/updates`; `GET /updates`, `/updates/unread_count`, `POST /updates/read`, `/updates/read_all`; email/SMS for Zoom link and lab results; Twilio OTP/Conversations; Segment/Datadog/LaunchDarkly telemetry. | Update `event_type`, `notifiable_type`, `notifiable_id`, `unread`, `created_at`, `sla_promise`, `pending_criteria_count`, `results_count`, `abnormal_results_count`. | `[CODE lib/store/api/updatesApi.ts:10-19,89-96,112-186]`; `[LIVE https://generalmedicine.co/using-zoom, 2026-10-19: “secure Zoom link we sent by text and email”]`; `[LIVE https://generalmedicine.co/api/external/skus/503263, 2026-10-19: “You’ll be notified by email and text”]`; `[LIVE https://generalmedicine.co/faq, 2026-10-19: “You’ll get a notification as soon as it’s sent”]`; `[CODE negative: no web push/service worker]`; `[DOC architecture.md §7.1 vendors 32–37]` |
| **E15** | D0 and D28 (PA branches) | If insured: may be told the drug needs prior authorization; waits “several business days”; if denied, may pay cash or switch. | Arrive Health RTPBI at pharmacy selection (`arrive_rtpbi_inquiry_id`), DoseSpot RTPB/eligibility, payer adjudication. No PA-submission endpoint observed. | PA requirement, formulary status, copay tier, `arrive_rtpbi_inquiry_id`, `insurance_status`. | `[CODE lib/store/api/pharmacyOrderApi.ts:90-103]`; `[DOC architecture.md §9.1 Step 3]`; `[LIVE https://generalmedicine.co/resources/using-a-glp-1-for-weight-loss, 2026-10-19: “prior authorization … generally takes several business days”]`; `[LIVE https://generalmedicine.co/api/external/product_detail_pages/710641, 2026-10-19: “Prior authorization is commonly required … we make that process seamless”]`; `[LIVE https://generalmedicine.co/assignment-of-benefits, 2026-10-19: PA is the patient’s/financially responsible party’s responsibility; patient financially responsible if denied]` |
| **E16** | Any time | Hits an exception: no Rx at the pharmacy, out of stock, PA denied, severe side effect, missed dose, abnormal lab, account blocked, holiday. | See §5. | — | see §5 |

### 1.1 Day-by-day summary: what is known vs inferred

| day | what happens | status |
|---|---|---|
| **D0 (first dose)** | On the same-day cash path: care plan is sent; prescription becomes a pharmacy order; patient selects pharmacy and billing mode; eRx is transmitted; patient is notified; first fill is picked up/delivered; first injection is self-administered. If the fill takes days (PA, out of stock, mail), D0 shifts to the first dose and the GM-side steps above happen before D0. No GM “first dose” event exists. | **Known:** care plan states/API, pharmacy order/checkout, notification promise, 4-pens-per-month packaging. **Inferred/Unknown:** click→visit→fill offset; exact hour of fill and first injection; no GM timestamp. `[CODE]` `[LIVE]` `[PUBLIC]` `[INFERENCE]` |
| **D7** | Second weekly dose. No GM event. If the patient has nausea/GI symptoms, they may message, use AI, or book a side-effect visit. | **Known:** once-weekly label; messaging/AI/side-effect SKU exist. **Inferred:** no reminder or check-in fires on D7. `[PUBLIC]` `[CODE]` `[INFERENCE]` |
| **D14** | Third dose. Same as D7. | Same. |
| **D21** | Fourth dose. After it, **all four doses in the 28-day box are used**; the next fill is due in 7 days and the refill window is open. GM’s `earliest_fill_date` and the refill reminder are the only system signals. | **Known:** `earliest_fill_date`, refill reminder promise, 4 doses per box. **Inferred:** reminder offset and whether it fires at D21 or later. `[CODE]` `[LIVE]` `[INFERENCE]` |
| **D28** | Box exhausted. If escalation is appropriate, the 5 mg box must already be in hand for the next dose. The medication check-in (questionnaire + optional labs) must be complete for a renewal; a clinician review decides 2.5 → 5 mg (or stay/lower/switch); a new Rx and new pharmacy order (and possibly a new PA) follow. | **Known:** check-in routes/APIs, review queue, phase-change ops, label escalation rule, 28-day supply, new-strength price. **Inferred:** whether GM’s default pathway requires a *visit* vs questionnaire-only at week 4; exact day the check-in unlocks. `[CODE]` `[PUBLIC]` `[LIVE]` `[INFERENCE]` |

**Bottom line on cadence.** The public GLP-1 guide is explicit: *“Expect monthly check-ins at first while your dose is being adjusted, then a shift to roughly every three months once you’re on a stable dose”*, and *“Stomach/digestive tolerance check-in — New start, each dose change, then ~every 3 months at a stable dose”* `[LIVE https://generalmedicine.co/resources/using-a-glp-1-for-weight-loss, 2026-10-19]`. The platform implements this as time-gated `CareJourney` criteria (`available_at`, `locked`, `deadline`) plus `NextStepCard` deadlines, not as a fixed cron visible to the client `[CODE lib/store/api/careJourneyApi.ts:58-71]` `[CODE lib/store/api/nextStepCardsApi.ts:27-37]`. The exact day offsets live in the server-side pathway/criteria set and were not recovered.

---

### 1.2 The five models behind the loop (what to build)

| model | authored / owned | what it is | how it shows up in weeks 1–4 | evidence |
|---|---|---|---|---|
| **`CarePathway` → `CarePathwayPhase` → `PhaseModality`** | Catalog admin (`createCarePathway`, `publishCarePathway`, `archiveCarePathway`, `createCarePathwayPhase`, `reorderCarePathwayPhases`, `updateCarePathwayLinkedSkus`, `createPhaseModality`) | A versioned clinical protocol: ordered phases, each with modalities and linked SKUs; draft → publish → archive. Visitron reads `getPublishedPathways` and moves a patient with `changePathway` / `changePhase`; `batchChangePatientMedicationPhases` does it in bulk. | `[INFERENCE]` The 2.5 mg → 5 mg step at week 4 is *likely* a **phase change** (and therefore a new linked SKU/strength, prescription and fill) because Visitron exposes `changePhase`/`batchChangePatientMedicationPhases`; the actual GLP-1 pathway/phase bindings were **not recovered**, so this is not an observed fact. | `[DATA osint/internal_portals_recon.json → catalog.rtk_endpoints, visitron.rtk_endpoints]`; `[DOC architecture.md §8.3, §8.2]` |
| **`Care::Plan`** | Visitron (AI draft → clinician review → `confirmCarePlan`) | The per-encounter plan object: `provider_message`, `patient_instructions`, next steps, state (`awaiting_curation` … `sent`). | The patient’s home page shows the plan and its next steps; `care_plan_ready` is an Updates event; `patient_rationale` explains “why this”. | `[CODE lib/store/api/carePlanApi.ts:7-22]`; `[CODE components/CareActions/careActionSection.ts:65-79]`; `[DOC architecture.md §8.2]` |
| **`CareJourney` criteria** | Server-side criteria set (Catalog `CriteriaSet`/`Requirement`; not recovered) | A checklist of `Lab` / `Questionnaire` / `Visit` criteria with `status`, `locked`, `available_at`, `deadline`, `estimated_minutes`, medication names, and lab-bundle metadata. This is the **check-in engine**. | The `/account/medication-check-in` hub, the Care Journey questionnaire/lab landings, and the `medication_check_in` care action. | `[CODE lib/store/api/careJourneyApi.ts:39-77]`; `[CODE lib/careJourney/checklist.ts:8-59]`; `[CODE components/CareActions/careActionSection.ts:154-165]` |
| **`NextStep` / `NextStep::PrescriptionRenewal` + `NextStepCard`** | Server-side; Visitron `createPatientMedicationPrescriptionRenewal`; patient `snooze`/`dismiss` | The actionable queue. Eight card kinds: `video_visit_follow_up`, `lab_order`, `questionnaire`, `imaging_order`, `referral_order`, `in_person_visit_order`, `prescription_order`, `medication_check_in`. Renewal carries `due_date`, `on_next_step`, `open_to_renew`. | The Next Steps queue; the week-4 renewal/check-in card; the “caught up” state. | `[CODE lib/store/api/nextStepCardsApi.ts:6-45]`; `[CODE lib/store/api/prescriptionRenewalApi.ts:5-22]`; `[CODE lib/store/api/prescriptionApi.ts:10-20]` |
| **`PharmacyOrder`** | Created by `ensure_pharmacy_order`; patient selects/pays; pharmacy fulfills | The dispense object: `state`, `billing_type`, `cash_price`, `insurance_price`, NCPDP id, cancel/switch flags. | The first fill and every subsequent fill; the `gm_card` counter pass. | `[CODE lib/store/api/pharmacyOrderApi.ts:15-24,26-118]`; `[DOC architecture.md §9.1]` |

**Check-in price.** The check-in itself (questionnaire + lab criteria) is **not a visit and has no separate visit fee** in the recovered contract; it is a criteria flow on the prescription. The `$25 / $30 / $100` grid applies only when a criterion is a `Visit`, or when the patient books a follow-up (`300550`), side-effect (`300348`), adjustment (`200010`), care video check-in (`300591`), or follow-up video visit (`400015`) `[CODE lib/store/api/careJourneyApi.ts:46-56]` `[LIVE https://generalmedicine.co/api/external/sku_options/300550, /300348, /200010, /300591, /400015, 2026-10-19]`.

## 2. Handoffs table

Every GM↔outside-party exchange on this path. “Direction” is data flow, not money flow.

| id | step | counterparty (company + product) | direction | what is exchanged (fields) | mechanism | trigger | who pays / fee | evidence |
|---|---|---|---|---|---|---|---|---|
| **H1** | E7 | **Emerald Medical Practice P.C.** (AZ/CA/KS), **Centennial Medical Practice P.C.** (ID), **Ruby Medical Practice P.C.** (NJ) — the professional corporations; **Path Healthcare Systems Corp.** is the administrative/management company (MSO role inferred) | GM → PC / PC → GM | Clinician identity, encounter, orders, care plan, prescription; the PC is the billing/furnishing entity | Internal employment/contract + Visitron/Athena; patient consent names the PCs | Visit, check-in review, dose change | Patient pays GM; the PC/clinician is paid by GM (contract terms undisclosed) | `[LIVE https://generalmedicine.co/telehealth-informed-consent, 2026-10-19: “Emerald … Centennial … Ruby … collectively ‘Emerald’”; “Path … does not provide the Services”]`; `[LIVE https://generalmedicine.co/assignment-of-benefits, 2026-10-19: “Emerald Medical Practice P.C. (the ‘Practice’)”]`; `[DOC architecture.md §7.5]` |
| **H2** | E1–E8 | **OpenLoop Health / Vital** and affiliate PCs (**Reliant.MD**, **MECNB**) | GM → clinician network / network → GM | Telehealth consultation furnished by an OpenLoop-affiliated PC; clinician identity/credentials | Separate telehealth consent page (`/vital-informed-consent`); provider network | If the visit is routed to the OpenLoop network | Patient pays GM; OpenLoop/PC paid by GM (undisclosed) | `[LIVE https://generalmedicine.co/vital-informed-consent, 2026-10-19: “Vital and affiliate Openloop Healthcare Partners, PC offer Telehealth consultations … Reliant.MD … MECNB”]`; `[DOC architecture.md §7.1 vendor 5]` |
| **H3** | E1, E8 | **DoseSpot** | GM ⇄ DoseSpot | Patient context, eligibility inquiry, formulary, draft/final prescription, EPCS identity | SSO redirect (`dose_spot_sso`) + REST (`prescription_eligibility_inquiries/*`) + NCPDP SCRIPT (attributed) | Clinician prescribes / renews / changes dose | GM pays SaaS; patient pays visit + drug | `[DOC architecture.md §7.1 vendor 2, §8.2]`; `[DATA osint/internal_portals_recon.json → visitron.api_paths: /dose_spot_sso, /dose_spot/prescription_eligibility_inquiries/]` |
| **H4** | E1.1, E15 | **Arrive Health** | GM ⇄ Arrive | Patient + drug + pharmacy → copay tier, deductible, formulary, prior-auth requirement; returns `arrive_rtpbi_inquiry_id` | REST `launch_benefit_inquiry`, `patient_context?patient_id=` | Pharmacy selection (before transmission) | GM pays SaaS; patient pays copay/cash | `[CODE lib/store/api/pharmacyOrderApi.ts:90-103]`; `[DOC architecture.md §9.1 Step 3]` |
| **H5** | E1, E7 | **Athenahealth** | GM ⇄ Athena | Encounter note, diagnoses, care plan, chart summary, `athena_id` | Visitron `sync_encounter_to_athena`, `care_plan_athena_resync`, `encounter_summary_athena_resync` | Clinician signs/publishes; care plan changes | GM pays SaaS | `[DOC architecture.md §7.1 vendor 1, §8.2]`; `[DATA … → visitron.rtk_endpoints]` |
| **H6** | E13 | **Metriport** + **Particle Health** | GM ⇄ HIE | Longitudinal records, prior prescriptions, labs, conditions, allergies; digested review injected into copilot context | REST `health_history/latest_metriport`, `trigger_metriport_sync`, `send_metriport_review_to_copilot` | AI prewarm (`gen-ai-prewarm-copilot`) or clinician prewarm | GM pays per retrieval | `[CODE lib/api/endpoints.ts:268-274]`; `[DOC architecture.md §7.1 vendors 27–28, §10.8]`; `[LIVE https://generalmedicine.co/faq, 2026-10-19: HIE records with consent]` |
| **H7** | E1.2–E1.4, E8–E9 | **LillyDirect Pharmacy** (NCPDP `1574056`) | GM → LillyDirect (eRx); LillyDirect → patient (drug) | NCPDP provider id, drug/strength/quantity/days supply, patient shipping/identity, payment; **no dispense status back in the recovered client contract** (whether GM receives a separate fill/dispense feed from LillyDirect or the PBM is Unknown — see §6) | eRx via NCPDP SCRIPT (attributed); GM cash checkout via Stripe (who captures/remits not observed); LillyDirect ships | Patient selects LillyDirect; cash path | Patient pays LillyDirect/GM $299/$399/$449; needles extra; GM routing margin unknown | `[LIVE https://generalmedicine.co/api/external/pharmacy_comparisons?medication_option_sku_id=710641…, 2026-10-19]`; `[PUBLIC https://www.lilly.com/lillydirect/zepbound]`; `[DOC architecture.md §9.1]` |
| **H8** | E1.2–E1.4, E8–E9 | **Amazon Pharmacy** (NCPDP `5919177`) | GM → Amazon (eRx); Amazon → patient | Same as H7 | eRx + Amazon delivery | Patient selects Amazon; cash path | Patient pays $299/$399/$449; GM margin unknown | `[LIVE https://generalmedicine.co/api/external/pharmacy_comparisons?medication_option_sku_id=710641…, 2026-10-19]`; `[CODE components/Refresh/SearchResults/searchPharmaciesUtils.ts:72-134]` |
| **H9** | E1.2–E1.4, E8–E9 | **CVS / Walgreens / Walmart / Costco / Safeway / Kroger / Rite Aid / Alto** | GM → pharmacy (eRx); pharmacy → patient | NCPDP id, drug/strength/quantity/days supply, billing type (`cash`/`insurance`/`pharmacy_delegation`), `gm_card` BIN/PCN/group/member | eRx via NCPDP SCRIPT (attributed); retail pickup; claim adjudication through the pharmacy switch | Patient selects retail; cash/insurance/delegation | Patient pays cash price or insurance copay at counter; GM may earn routing margin (unknown) | `[LIVE https://generalmedicine.co/api/external/pharmacy_comparisons?medication_option_sku_id=710641…, 2026-10-19]`; `[CODE components/Refresh/SearchResults/searchPharmaciesUtils.ts:1-134]`; `[DOC architecture.md §9.1]` |
| **H10** | E1.3, E8 | **Stripe** | GM ⇄ Stripe | SetupIntent, `payment_method_id`, card charge, 3DS, refunds | REST + Stripe.js/Elements; `create_stripe_setup_intent`, `previous_fill_payment_method` | Cash/gm_card checkout; visit booking | Patient pays; GM pays processing | `[CODE lib/api/endpoints.ts:321-329]`; `[CODE lib/store/api/paymentServiceApi.ts:18-21]`; `[DOC architecture.md §7.1 vendor 30]`; `[LIVE https://generalmedicine.co/privacy-policy, 2026-10-19: “Our payment processor is Stripe”]` |
| **H11** | E3, E14 | **Twilio** | GM ⇄ Twilio | Chat/conversation token, messages, attachments, OTP SMS | Twilio Conversations (JWT) + Cognito CUSTOM_AUTH → Twilio Lambda for OTP; SMS short code 98528 | Patient messages / logs in / receives OTP | GM pays per message/OTP; patient pays carrier SMS | `[CODE lib/api/endpoints.ts:59-67]`; `[CODE lib/store/api/messageCenterApi.ts:168-175]`; `[DOC architecture.md §7.1 vendor 32, §10.7]`; `[LIVE https://generalmedicine.co/api/external/tenant_integrations/phone_number → 98528, 2026-10-19]` |
| **H12** | E14 | **Zoom** | GM → patient | Unique `meeting_url`, meeting id/passcode | Link sent by SMS and email; Zoom app/browser | Video visit booked | GM pays Zoom; patient pays visit | `[CODE lib/api/endpoints.ts:82-93]`; `[LIVE https://generalmedicine.co/using-zoom, 2026-10-19]`; `[DOC architecture.md §7.1 vendor 33]` |
| **H13** | E6 | **Quest Diagnostics / Labcorp / BioReference** | GM → lab (order); lab → GM (results) | Test codes, requisition, accession number, result PDF/HL7/FHIR, `clinical_fee` | Lab order via GM; PSC draw; results to EHR/dashboard; external PDF upload to S3 | Check-in labs or baseline labs | Patient pays GM (panel + $15 clinical fee); GM pays lab wholesale | `[CODE lib/api/endpoints.ts:249-252]`; `[LIVE https://generalmedicine.co/api/external/lab_skus/503263, 2026-10-19]`; `[DOC architecture.md §9.2]` |
| **H14** | E6 | **AWS S3** (or Nile-Core, depending on transport) | Patient browser → S3 → GM | External lab PDF bytes, file id, presigned URL, upload `state`/`ready`, then the check-in completion | **Direct-S3 path:** `POST /file_uploads/presign` → browser `PUT` to S3 → `POST /file_uploads/{id}/complete` (marks the upload ready) → `POST /care_journey/complete_lab_upload` (finalizes the check-in). **Legacy path:** base64 JSON → `POST /file_uploads` on Nile-Core. The check-in page’s chosen transport is not recovered; direct-S3 is a tenant capability (`directToS3FileUpload`). | Patient chooses “upload my labs” instead of drawing | Patient pays nothing extra; GM pays storage | `[CODE lib/fileUpload/directUpload.ts:1-90 (presign → S3 PUT → file_uploads/{id}/complete)]`; `[CODE lib/store/api/fileUploadApi.ts:88-140 (legacy base64 vs direct-S3)]`; `[CODE lib/api/endpoints.ts:225-233]`; `[CODE lib/store/api/careJourneyApi.ts:161-177]`; `[DOC architecture.md §9.2, §11.3]` |
| **H15** | E14 | **Email provider (unidentified)** | GM → patient | Visit link, lab-result notice, prescription-sent notice, care-plan notice | Email (SMTP/API vendor not observed) | Visit booked; lab resulted; Rx sent | GM pays vendor | `[LIVE https://generalmedicine.co/using-zoom, 2026-10-19: link sent by text and email]`; `[LIVE https://generalmedicine.co/api/external/skus/503263, 2026-10-19: notified by email and text]`; `[CODE negative: no SendGrid/Postmark/Mailgun/Klaviyo/CIO/Braze token]`; vendor Unknown |
| **H16** | E13 | **Braintrust** | GM → Braintrust | AI span scoring, thumbs-up/down category/comment | `/api/chat/feedback` → server-side span score | Patient rates an AI answer | GM pays | `[CODE lib/store/api/assistantFeedbackApi.ts:1-66]` |
| **H17** | E14 | **Segment / Datadog / LaunchDarkly / Metabase + Databricks** | GM → vendors | Product events, RUM/session replay, flag evaluations, BI | SDK/JS + server pipeline | Every page/flag/error | GM pays | `[CODE packages/mantine-theme/analytics/events.ts:1-60]`; `[CODE lib/analytics/datadogRum.ts]`; `[DOC architecture.md §7.1 vendors 35–37, §8.7]` |
| **H18** | E2, E16 | **Eli Lilly** (IFU, Medication Guide, savings program, MedWatch) | Lilly → patient; patient → Lilly/FDA | Instructions for Use, Medication Guide, savings enrollment, adverse-event report | Paper insert / LillyDirect / Lilly call center 1-800-LillyRx; FDA MedWatch | First fill; side effect; savings | Patient pays (drug/needles); Lilly may subsidize | `[PUBLIC https://pi.lilly.com/us/zepbound-uspi.pdf: “To report SUSPECTED ADVERSE REACTIONS, contact Eli Lilly … or FDA at 1-800-FDA-1088”]`; `[PUBLIC https://www.lilly.com/lillydirect/zepbound: savings automatically applied through LillyDirect]` |

---

## 3. Ops touchpoints (human action)

| role | queue / tool | what they do on this path | trigger | SLA if known | evidence |
|---|---|---|---|---|---|
| **Prescriber (MD/NP)** | Visitron encounter | Reviews prewarmed chart, examines/talks, diagnoses, prescribes, signs encounter, confirms care plan | Initial GLP-1 visit; follow-up; side-effect/adjustment visit | Visit availability “today” for video on 300543/300550; async review 24–48h for new AI customers | `[CODE lib/api/endpoints.ts:82-93]`; `[LIVE https://generalmedicine.co/api/external/sku_options/300543 → video availability_promise “today”, 2026-10-19]`; `[LIVE https://generalmedicine.co/ai: 24–48h]`; `[DOC architecture.md §8.2]` |
| **Check-in reviewer** | Visitron `getPendingReview`, `createNextStepReview`, `generateNextStepReview`, `updateNextStepReview`, `applyReview`, `rejectReview`, `confirmCarePlan`, `confirmNoChange` | Reviews the week-4 questionnaire/labs; accepts/edits/rejects the AI-drafted next-step review; decides dose change | Medication check-in completed (or lab resulted) | No SLA observed | `[DATA osint/internal_portals_recon.json → visitron.rtk_endpoints]`; `[DOC architecture.md §8.2]` |
| **Prescriber doing the dose change** | Visitron `changePhase`, `changePathway`, `batchChangePatientMedicationPhases`, `createPatientMedicationPrescriptionRenewal`, `updatePatientMedicationDaysSupply`, `clearPatientMedicationDaysSupply`, `updatePatientMedicationCourseType` | Changes the patient’s medication phase/strength, writes the new Rx, sets days supply/course type; may create the renewal next step | Week-4 review; intolerance; plateau; switch | No SLA observed | `[DATA … → visitron.rtk_endpoints]`; `[DOC architecture.md §8.2]` |
| **Inbound refill reviewer** | Visitron `listInboundRequests`, `approveInboundRequest`, `denyInboundRequest` | Approves/denies pharmacy-initiated refill/renewal requests (the pharmacy asks the prescriber) | Pharmacy sends an inbound request at/near the refill date | Public claim: “most refill requests … reviewed and confirmed the same day” | `[DATA … → visitron.rtk_endpoints]`; `[DOC architecture.md §8.2]`; `[LIVE https://generalmedicine.co/resources/medication-faqs, 2026-10-19]` |
| **Care team / support agent** | SMS 98528; Message Center `/account/messages` (Twilio); help@/hello@/support@navhealth.co | Answers “where is my Rx”, side-effect questions, billing/refund questions, reschedules; routes clinical questions to a clinician | Patient texts/messages/emails; pharmacy failure | Per-thread `response_expectation` (server-driven, e.g. “Clinician will respond within 2 hours” per dossier); support hours M–F 9–9 ET / 7–7 MT except federal holidays | `[CODE hooks/useContactSupport.ts:10,59-92]`; `[CODE lib/store/api/messageCenterApi.ts:44-58]`; `[LIVE https://generalmedicine.co/faq: M–F 9–9 ET]`; `[LIVE https://generalmedicine.co/telehealth-informed-consent: M–F 7–7 MT except federal holidays]`; `[DOC architecture.md §10.7]` |
| **Clinical reviewer for abnormal labs** | Visitron lab/result review; Updates `abnormal_results_count` | Reaches out to the patient when levels are out of range; recommends next step | Lab resulted abnormal | No SLA; “will reach out” | `[CODE lib/store/api/updatesApi.ts:86-88]`; `[LIVE https://generalmedicine.co/resources/labs-faqs, 2026-10-19]` |
| **Pharmacy staff** | Retail/specialty pharmacy | Counsels on injection at pickup; adjudicates claim; may send an inbound refill request; may report out-of-stock | First fill; refill; PA | No GM SLA | `[PUBLIC https://pi.lilly.com/us/zepbound-uspi.pdf §2.4: train patients on presentation]`; `[DOC architecture.md §9.1]`; `[DATA … → visitron.rtk_endpoints: listInboundRequests]` |
| **Prior-auth / RCM** | No dedicated PA tool observed; Arrive Health RTPBI + DoseSpot RTPB + Waystar claims; Visitron notes | Works the PA, documents, re-runs benefit check; may switch drug/pharmacy | PA required/denied; dose change | Public: “several business days” | `[LIVE https://generalmedicine.co/resources/using-a-glp-1-for-weight-loss, 2026-10-19]`; `[DOC architecture.md §7.1 vendors 6–7, §9.1]`; `[INFERENCE] manual/fax/ePA workflow; no PA endpoint recovered` |
| **AI / prompt engineer** | Provider Chat / Promptimus; Braintrust; Datadog | Tests/tunes the copilot prompt, model version, temperature; reviews thumbs-down clusters | AI quality issue; new clinical content | None | `[DOC architecture.md §8.5, §10.8]`; `[CODE lib/store/api/assistantFeedbackApi.ts]` |
| **Growth / lifecycle** | Segment, Datadog, Metabase; no marketing-automation tool observed | Watches dashboard/check-in/refill funnel; manual outreach if at all | Refill lapse; check-in non-completion | None | `[CODE packages/mantine-theme/analytics/events.ts:44-52]`; `[DOC architecture.md §8.7]`; `[INFERENCE] no Braze/Iterable/Klaviyo observed` |

**Staffing implication.** The only *productized* clinical queues on this path are Visitron’s next-step review and inbound-request queues. There is no observed GLP-1-specific adherence queue, no refill-lapse queue, and no after-hours clinical triage queue. The support surface is a short code, an in-app chat (flagged), and three email addresses across two domains (`help@generalmedicine.co`, `hello@generalmedicine.co`, `support@navhealth.co`), plus two published phone numbers (`(801) 251-6055` in the footer, `(801) 255-6051` in the telehealth consent for technical failure) `[LIVE https://generalmedicine.co/telehealth-informed-consent]` `[LIVE https://generalmedicine.co/faq]`.

---

## 4. Money (month 1)

### 4.1 Visit fees (the only GM-controlled recurring charge)

| item | cash | insurance | evidence |
|---|---:|---:|---|
| GLP-1 medication evaluation (`300543`) — video | **$100** | **$25 typical copay** | `[LIVE https://generalmedicine.co/api/external/sku_options/300543, 2026-10-19]`; `[LIVE https://generalmedicine.co/s/glp-1-medication-evaluation/300543: “Video Visit $25 Est. or $100 w/o insurance · Chat Visit $30 w/o insurance”]` |
| GLP-1 medication evaluation — chat | **$30** | not offered | same |
| Weight loss follow-up (`300550`) — video / chat | **$100 / $30** | **$25** | `[LIVE https://generalmedicine.co/api/external/sku_options/300550]`; `[LIVE https://generalmedicine.co/s/weight-loss-follow-up/300550]` |
| Medication side effect (`300348`) — video / chat | **$100 / $30** | **$25** | `[LIVE https://generalmedicine.co/api/external/sku_options/300348]`; `[LIVE https://generalmedicine.co/s/medication-side-effect/300348]` |
| Medication adjustment (`200010`) — video only | **$100** | **$25** | `[LIVE https://generalmedicine.co/api/external/sku_options/200010]`; `[LIVE https://generalmedicine.co/s/medication-adjustment/200010]` |
| Care video check-in (`300591`) — video only | **$100** | **$25** | `[LIVE https://generalmedicine.co/api/external/sku_options/300591]`; `[LIVE https://generalmedicine.co/api/external/skus/300591: “A short conversation with your clinician to finalize your care.”]` |
| Follow-up video visit (`400015`) — video only | **$100** | **$25** | `[LIVE https://generalmedicine.co/api/external/sku_options/400015]` |
| Prescription renewal (`200007` / `400020`) — video / chat | **$100 / $30** | **$25** | `[LIVE https://generalmedicine.co/api/external/sku_options/200007, /400020]`; `[LIVE https://generalmedicine.co/s/prescription-renewal/200007: same grid]` |

The `$25` is a **typical copay estimate**, not a guarantee: the canonical constant is `TYPICAL_VISIT_COPAY_CENTS = 2500`, matching Nile-Core `Sku::TYPICAL_COPAY` `[CODE lib/productDetailPage/resolveMedicationOptionVisitCost.ts:4]`. The PDP labels it “typical copay” for logged-out visitors and “est. insurance price” for authenticated patients `[CODE components/ProductDetailPage/MedicationPriceCard.tsx:14-19,30-45]`.

**Price presentation nuance.** The bulk prices endpoint returns, for 300543/300550/300348, top-level cash **$30** and insurance **$25** with `primary: true` on insurance (the minimum cash option is chat) `[LIVE https://generalmedicine.co/api/external/sku_options/prices?sku_ids[]=300543…, 2026-10-19]`. The visit SKU card therefore advertises “$30 without insurance” while the video option is $100. The visit-options page disambiguates. This is a real price-shock risk for uninsured video patients.

### 4.2 Medication (the dominant month-1 cost)

| presentation | 2.5 mg | 5 mg | 7.5–15 mg | evidence |
|---|---:|---:|---:|---|
| **Zepbound KwikPen** (`710641`/`710643`/`710644`…) | **$299** | **$399** | **$449** | `[LIVE https://generalmedicine.co/api/external/medication_option_skus/710641/cash_price?zip_code=94107 → 29900; 710643 → 39900; 710644 → 44900, 2026-10-19]` |
| **Zepbound single-dose pen / auto-injector** (`710642`…) | **$1,074.09** | **$1,074.09** | **$1,074.09** | `[LIVE …/710642/cash_price → 107409; 710646/710649 → 107409, 2026-10-19]` |
| **Zepbound vial** (`701542`, `706142`, …) | **no cash price** | no cash price | no cash price | `[LIVE …/701542/cash_price → null, 2026-10-19]` |
| **Retail cash (2.5 mg)** | Walgreens/Costco/Safeway/Walmart **$496.12**; CVS **$508.09** | $496.12 / $508.09 | $496.12 / $508.09 | `[LIVE https://generalmedicine.co/api/external/pharmacy_comparisons?medication_option_sku_id=710641&latitude=37.7749&longitude=-122.4194, 2026-10-19]` |
| **LillyDirect/Amazon cash** | **$299** | **$399** | **$449** | same live endpoint |

The KwikPen cash ladder is the **LillyDirect self-pay ladder**, not a GM invention: 2.5 mg $299/mo, 5 mg $399/mo, 7.5–15 mg $449/mo *when you refill within 45 days*; late refills are $499 (7.5) / $699 (10–15). A “month” is **28 days and 1 single-patient-use KwikPen**; pen needles are a separate purchase `[PUBLIC https://www.lilly.com/lillydirect/zepbound]`. Single-dose pens include the needle; with commercial insurance the single-dose pen can be “as low as $25/month for up to a 3-month prescription” through the savings card `[PUBLIC same]`.

**This is the single most important week-4 economic fact:** escalating 2.5 → 5 mg raises the cash price **$299 → $399** at LillyDirect/Amazon, while retail cash stays ~$496–$508. A patient who chose the single-dose pen instead of the KwikPen sees **$1,074.09** at cash checkout — 3.6× the KwikPen. Presentation selection is therefore a cost decision, not a cosmetic one.

**What the patient sees before the visit:** “With insurance — Available after visit” (tooltip: “Your insurance price is set by your specific plan, so we can only check it once you have a prescription”), plus the drug cash price and a “+ $25 typical copay for visit” footer `[CODE components/ProductDetailPage/MedicationPriceCard.tsx:14-45,110-130]` `[LIVE https://generalmedicine.co/api/external/product_detail_pages/710641: “insurance price is never resolvable on the PDP” comment in code]`. Insurance price is only resolved after the prescription exists and the pharmacy is selected.

### 4.3 Labs (only if the check-in requires them)

| item | cash | evidence |
|---|---:|---|
| Comprehensive GLP-1 Lab Panel (`503263`) — Quest | **$86.58** total ($71.58 test + **$15.00 clinical fee**) | `[LIVE https://generalmedicine.co/api/external/lab_skus/503263, 2026-10-19]` |
| same — Labcorp | **$109.67** ($94.67 + $15.00) | same |
| same — BioReference | **$102.20** ($87.20 + $15.00) | same |
| Insurance price | **null** on all three (displayed as “Priced after visit” / estimated copay) | same; `[CODE lib/store/api/pharmacyOrderApi.ts:73-88]` |

The panel is 5 tests (CMP, lipid, TSH w/ reflex Free T4, CBC, HbA1c), “Results in 48 hours, expertly reviewed” `[LIVE …/lab_skus/503263]`. The `$15.00` is the live server-driven clinical fee; **$30 is only the client fallback** when the fee is missing `[CODE types/enums/lab-pricing-constants.ts:8]` `[DOC adversarial-and-market-report.md §1.5]`.

### 4.4 Rules and non-charges

| rule | amount / behavior | evidence |
|---|---|---|
| Subscription | **None.** “No subscription needed.” Refill ordering is always the patient’s step; GM does not auto-charge. | `[LIVE https://generalmedicine.co/p/lilly/weight-loss]`; `[CODE lib/hardcoded-data/CategoryPages/medications.ts:156-157]` |
| Auto-refill | **No auto-charge.** GM notifies, patient reorders; payment method/pharmacy can change before ordering. | same |
| Cancellation fee | Charged to card on file for <24h cancellation/no-show; **Medicaid patients exempt**; reschedule free; visit fee refunded in **5–10 business days**; no refunds for services provided or for the fee itself. | `[LIVE https://generalmedicine.co/cancellation-policy, 2026-10-19]` |
| Lab refund | Full refund up to **6 months** if the sample has not been collected; **no fee deduction**; same across labs; request by SMS 98528 or support@navhealth.co. | `[LIVE https://generalmedicine.co/refund-policy-labs, 2026-10-19]` |
| Prior auth | “Several business days”; PA is legally the patient’s/financially responsible party’s responsibility; patient financially responsible if denied or retrospectively deemed not medically necessary. | `[LIVE https://generalmedicine.co/resources/using-a-glp-1-for-weight-loss]`; `[LIVE https://generalmedicine.co/assignment-of-benefits]` |
| HSA/FSA | Eligible for visits and labs. | `[LIVE https://generalmedicine.co/faq]` |
| Clinical review fee on a pharmacy order | `clinical_fee_cents` exists and is charged separately; **amount not observed**. | `[CODE lib/utilities.ts:949-979]`; `[DOC architecture.md §9.1]` |
| Pharmacy routing fee | Unknown; GM may earn a margin on `gm_card`/routing. | `[INFERENCE]`; `[DOC adversarial-and-market-report.md §3.4]` |

### 4.5 Illustrative month-1 totals (cash, no insurance)

| scenario | visit | drug | labs | total |
|---|---:|---:|---:|---:|
| Video visit, KwikPen 2.5 mg at LillyDirect, no labs | $100 | $299 | $0 | **$399** |
| Chat visit, KwikPen 2.5 mg at LillyDirect, GLP-1 panel at Quest | $30 | $299 | $86.58 | **$415.58** |
| Video visit, KwikPen 2.5 mg at retail (Walgreens), no labs | $100 | $496.12 | $0 | **$596.12** |
| Video visit, single-dose pen at cash list, no labs | $100 | $1,074.09 | $0 | **$1,174.09** |
| Through the week-4 second fill: video visit + week-4 follow-up + initial 2.5 mg box + escalated 5 mg box, no labs | $200 | $698 ($299 + $399) | $0 | **$898** |

These are arithmetic on observed prices, not quotes `[INFERENCE]` for the totals. **Month-1 spend alone** (initial visit + first box) is **$399** in the cheapest row; the week-4 follow-up and second box are next-cycle costs. Through the second fill the cheapest total is **$898** ($200 visits + $698 drug). The point is the spread: **$399 to $1,174** for the first month depending on modality, presentation and pharmacy.

---

## 5. Failure modes & branches

| branch / failure | what happens | who acts | evidence |
|---|---|---|---|
| **Pharmacy never receives the eRx / patient sees no Rx** | The client has no “pharmacy received/acknowledged” endpoint and no dispense feed. The order exposes `state` plus `can_cancel_pharmacy_order` / `can_switch_pharmacy` / `can_choose_new_pharmacy`; the practical remedy is cancel + re-route. The patient is the error detector (call/text). | Patient + care team; maybe prescriber re-send | `[CODE lib/store/api/pharmacyOrderApi.ts:15-24,46-59]`; `[LIVE https://www.bbb.org/... and https://uk.trustpilot.com/review/generalmedicine.co?page=4 via DOC adversarial-and-market-report.md §3.6: “visited the pharmacy 3 times, with no prescription in my name”]`; `[INFERENCE] no NCPDP dispense/ack status observed` |
| **Out of stock (GLP-1 pen)** | No inventory API observed. The compare drawer pins LillyDirect/NovoCare and Amazon as cold-chain/mail alternatives and interleaves 2 retail : 1 online, so the patient can switch. `cancel {pharmacy_change: true }` reopens the compare drawer with `can_choose_new_pharmacy: true`. | Patient + pharmacy + care team | `[CODE components/Refresh/SearchResults/searchPharmaciesUtils.ts:72-134]`; `[CODE lib/store/api/pharmacyOrderApi.ts:46-59]`; `[DOC architecture.md §9.1 Step 7]` |
| **PA required** | RTPBI returns the PA requirement at pharmacy selection. GM markets “seamless” PA, but the legal terms put PA responsibility and denial risk on the patient. Work takes “several business days.” | PA/RCM + prescriber + patient | `[CODE lib/store/api/pharmacyOrderApi.ts:90-103]`; `[LIVE PDP FAQ]`; `[LIVE AOB]`; `[LIVE GLP-1 article]` |
| **PA denied** | Options: cash (LillyDirect $299+), switch drug/strength, or appeal. The visit fee is not refunded (“no refunds for services we have provided”). | Patient + prescriber + PA team | `[LIVE cancellation policy]`; `[LIVE PDP FAQ: Medicare Part D often does not cover weight management alone]` |
| **Insurance does not cover weight loss** | Cash path is shown after the visit; LillyDirect/Amazon $299/$399/$449; retail $496–$508. | Patient | `[LIVE PDP FAQ]`; `[LIVE comparisons]` |
| **Dose escalation not tolerated / patient wants to stay at 2.5 mg** | Clinician can keep the current phase, lower it, or switch. The label says 2.5 mg is *not* a maintenance dose; the follow-up FAQ says the clinician walks through “increasing versus staying.” | Prescriber | `[PUBLIC label §2.1]`; `[LIVE https://generalmedicine.co/s/weight-loss-follow-up/300550]` |
| **Dose escalation requires a new PA** | New strength = new NDC; a new PA/step-therapy edit is common. The new fill can be delayed past day 28; the patient may miss a dose. | PA/RCM + prescriber + patient | `[INFERENCE]` based on new `medication_option_sku_id` + RTPBI + “several business days”; `[CODE lib/store/api/pharmacyOrderApi.ts:90-103]` |
| **Severe GI side effect (nausea/vomiting/diarrhea, dehydration)** | Message/care team, book `300348` Medication Side Effect (video $100/$25, chat $30) or `200010` Medication Adjustment (video $100/$25); clinician may hold/lower dose or stop. Emergency → 911; GM’s providers “do not address medical emergencies.” No 24/7 clinical line observed. | Patient + care team + prescriber | `[LIVE https://generalmedicine.co/s/medication-side-effect/300348]`; `[LIVE https://generalmedicine.co/s/medication-adjustment/200010]`; `[LIVE https://generalmedicine.co/telehealth-informed-consent: emergency instructions, M–F hours]`; `[PUBLIC label §5.2–5.3]` |
| **Patient stops the drug abruptly** | The side-effect FAQ explicitly says do not stop abruptly without clinical guidance (for the drug classes listed); GLP-1 is not in that list but the advice is generic. No GM “stop treatment” workflow. | Patient + prescriber | `[LIVE https://generalmedicine.co/s/medication-side-effect/300348 FAQ]`; `[PUBLIC label §8.1: discontinue when pregnancy is recognized]` |
| **Missed dose** | Label: take within 4 days (96 h); if more, skip and resume the regular day; the dosing day can change if ≥3 days between doses. GM has no automated missed-dose flow; the AI example prompt covers it. | Patient; AI/messaging for guidance | `[PUBLIC label §2.3]`; `[CODE components/Refresh/AIPage/IdeasSection/IdeasSection.tsx:27]` |
| **Check-in not completed** | The prescription shows `has_pending_criteria` / `criteria_deadline`; the renewal is gated. No auto-refill. The patient can snooze/dismiss the card (dismissal ≠ completion). | Patient + care team | `[CODE lib/store/api/dashboardApi.ts:27-43]`; `[CODE lib/store/api/nextStepCardsApi.ts:98-171]`; `[INFERENCE] dismissal leaves criteria pending` |
| **Check-in labs not drawn / external PDF instead** | Patient can upload an external PDF. Direct-S3 path: presign → S3 PUT → `file_uploads/{id}/complete` → `care_journey/complete_lab_upload` → progress; legacy path posts base64 to Nile-Core. The check-in page’s transport is not recovered; either way the file is then attached/shared for review. | Patient + clinical reviewer | `[CODE lib/fileUpload/directUpload.ts:1-90]`; `[CODE lib/store/api/fileUploadApi.ts:88-140]`; `[CODE lib/api/endpoints.ts:225-233]`; `[CODE lib/store/api/careJourneyApi.ts:161-177]`; `[DOC architecture.md §9.2]` |
| **Abnormal lab** | A licensed clinician reviews; if out of range, the clinical team reaches out directly to review and recommend next steps. | Clinical reviewer | `[LIVE https://generalmedicine.co/resources/labs-faqs, 2026-10-19]`; `[CODE lib/store/api/updatesApi.ts:86-88]` |
| **Refill lapse >45 days (≥7.5 mg at LillyDirect)** | Price jumps from $449 to $499 (7.5) or $699 (10–15). | Patient | `[PUBLIC https://www.lilly.com/lillydirect/zepbound]` |
| **Refill lapse (any dose)** | No auto-refill; the patient runs out; no adherence outreach observed. | Patient; no queue | `[CODE lib/hardcoded-data/CategoryPages/medications.ts:156-157]`; `[INFERENCE]` |
| **Cancellation <24h** | Fee charged to card on file; Medicaid exempt; visit fee refunded 5–10 business days; reschedule free. | Patient + support | `[LIVE https://generalmedicine.co/cancellation-policy]` |
| **Pharmacy order cancel/switch** | `POST /pharmacy_orders/{id}/cancel {pharmacy_change}` returns cancel/switch/choose-new flags; when `pharmacy_change` is true the backend voids NCPDP routing and reopens compare. | Patient self-serve | `[CODE lib/store/api/pharmacyOrderApi.ts:46-59]`; `[DOC architecture.md §9.1 Step 6]` |
| **Decline a renewal** | `POST /next_step_prescription_renewals/{id}/decline {cancellation_reason}`; or `completed_elsewhere`; invalidates prescription/dashboard. | Patient | `[CODE lib/store/api/prescriptionRenewalApi.ts:159-177]` |
| **Account blocked** | The dashboard renders only a notice, no shell/nav. Cause not exposed to the client. | Support | `[CODE hooks/useAccountDashboardActive.ts:8-16 comment: “Blocked accounts render only a notice with no dashboard chrome”]` |
| **Support closed (weekend/federal holiday)** | No 24/7 clinical line; emergency is 911. Visits may still be available after hours/weekends depending on clinician supply. | Patient | `[LIVE consent: M–F 7–7 MT except federal holidays]`; `[LIVE FAQ: visits often available after hours/weekends]` |
| **Walmart tenant** | General AI is hard-disabled (`generalAi:false`), direct SMS to care team is disabled (`textCareTeam:false`); the patient is routed to portal/phone and the Walmart app. this file’s DTC behavior does not apply. | Tenant config | `[CODE config/tenants/walmartPublic.ts:42-50]`; `[DOC architecture.md §11.3]` |

**The failure pattern to plan for.** GM’s clinical workflow is more instrumented than its *fulfillment* workflow. The clinical side has queues, AI drafts, reviews and escalation SKUs. The pharmacy side has a one-way transmission, three cancel flags, and **no acknowledgment/dispense feed in the recovered client contract** (whether a server-side feed exists is Unknown — see §6). The 1★ review tail (“no prescription in my name”) is exactly this gap `[DOC adversarial-and-market-report.md §3.6]`.

---

## 6. Open questions

1. **Exact week-4 trigger.** Does the GLP-1 pathway require a *visit* (`300550` / `400015` / `300591`), a *questionnaire only*, or *questionnaire + labs* before the next fill? The `CareJourney` model supports all three types and time gates (`available_at`, `locked`, `deadline`), but the GLP-1 criteria set is server-side and was not recovered. `[CODE lib/store/api/careJourneyApi.ts:58-71]`
2. **Check-in day offsets.** Is the first check-in at day 28, day 30, or “before the next fill”? The public guide says monthly; the code has no fixed cron. `[LIVE GLP-1 article]` `[CODE]`
3. **Questionnaire content and length.** The check-in is a multi-question questionnaire with `questionnaire_length` and progress, but the question text and count are not in the recovered tree and the live `/api/external/questions/{id}/{n}` returns 401. `[CODE lib/store/api/careJourneyApi.ts:130-138]`
4. **Which labs the GLP-1 check-in bundles.** `503263` is explicitly “Monitor … while on GLP-1 therapy” and is the obvious candidate, but the bundle is per-prescription (`patient_medications/{id}/lab_bundle`) and the actual `skus[]` list was not observed. `[LIVE 503263]` `[CODE lib/store/api/prescriptionApi.ts:54-71]`
5. **Who reviews the check-in.** Any on-call clinician, the prescriber, or a dedicated GLP-1 panel? Visitron has a generic pending-review queue; there is no GLP-1-specific assignment observed. `[DATA visitron.rtk_endpoints]`
6. **Email/SMS delivery vendor and templates.** Twilio covers OTP/Conversations; the email vendor is not identified in the client, and the exact refill-reminder channel/cadence is unknown. `[CODE negative]`
7. **PA submission mechanism and turnaround.** No PA-submission endpoint was observed; Arrive Health/DoseSpot return the requirement, Waystar handles claims, but who submits the PA (ePA, fax, portal) and the real median turnaround are unknown. `[CODE]` `[DOC §7.1]`
8. **Clinical review fee on pharmacy orders.** `clinical_fee_cents` exists; the amount and whether GLP-1 orders carry it are unknown. `[CODE lib/utilities.ts:949-979]`
9. **Cancellation fee amount.** The policy says a fee is charged but does not publish the amount. `[LIVE cancellation policy]`
10. **Whether GM earns a pharmacy routing margin.** The `gm_card` and pharmacy delegation imply a switch relationship; the economics are undisclosed. `[DOC adversarial-and-market-report.md §3.4]` `[INFERENCE]`
11. **Whether the AI copilot can see the active prescription/dose.** The chat has a health-details modal with `HealthMedication {name, dose_value}` and Metriport prewarm, but the prompt context and whether it includes the current GM prescription are not in the recovered client. `[CODE components/HealthDetailsModal.tsx:41]` `[CODE hooks/useGeneralAiStatus.tsx]`
12. **Whether care-team messages are answered by a licensed clinician.** The UI says “care team”; the dossier says “Clinician will respond within 2 hours”; the storyboard calls it a “Care Coordinator Message Center.” The staffing model is not established. `[DOC architecture.md §10.7]` `[LIVE GLP-1 article]`
13. **Whether the patient can choose the Zepbound presentation.** The PDP lets the patient select KwikPen / auto-injector / vial and routes to that `medication_option_sku_id`; whether the prescriber honors it is unknown. This is the difference between $299 and $1,074 cash. `[CODE components/ProductDetailPage/RequestPrescriptionCta.tsx:18-48]` `[LIVE cash prices]`
14. **Needle supply.** KwikPen requires a separate pen-needle purchase; GM sells no needle SKU (only a visit for diabetes supplies, `300467`). Whether the pharmacy/care team tells the patient is unknown. `[PUBLIC LillyDirect]` `[LIVE 300467]`
15. **Which professional corporation furnishes the DTC GLP-1 visit.** The telehealth consent names Emerald/Centennial/Ruby; the separate “Vital Informed Consent” names OpenLoop/Reliant.MD/MECNB. Which consent is shown for which path is not established. `[LIVE both pages]`
16. **After-hours clinical escalation.** No nurse line, on-call clinician pager, or symptom-triage engine was observed; the only emergency instruction is 911. `[LIVE consent]` `[CODE negative]`
17. **Refill reminder offset and channel.** `earliest_fill_date` is the gate; the reminder may be email, SMS, in-app, or none. `[CODE]` `[LIVE consent]`
18. **Whether the week-4 follow-up is free/included.** The public model is fee-for-visit; no subscription/bundled follow-up was observed. `[LIVE Lilly page “No subscription needed”]`
19. **Check-in dismissal semantics.** `snooze` and `dismiss` remove the card; whether the underlying criteria remain pending (and therefore block renewal) is not visible client-side. `[CODE nextStepCardsApi]`
20. **Adherence measurement.** GM has no dose log; whether it buys fill data from a pharmacy/PBM switch or infers from its own orders is unknown. `[CODE negative]` `[INFERENCE]`

---

## 7. Handoff to other evidence files

- **Cross-reference to evidence A (acquisition):** the SEO→visit path and the $25/$30/$100 price ladder are shared; E confirms the *post-visit* price presentation and the $299/$399/$449 drug ladder. Do not attribute the $25 to the drug.
- **Cross-reference to evidence C (intake):** E1 depends on the GLP-1 evaluation’s screening/history questionnaires (`300543` UUIDs `11340c6b…`, `3cdcfa37…`). The check-in questionnaire is a *separate* renewal-criteria questionnaire, excluded server-side from `dashboard/show` `[CODE lib/store/api/dashboardApi.ts:14]`.
- **Cross-reference to evidence D (checkout/labs):** E1.1–E1.4 uses the same `PharmacyOrder` and Stripe path D maps; E adds the *refill* and *new-strength* re-entry, and the 28-day/45-day timing. The `gm_card` BIN/PCN/group/member is the delegation path.
- **Cross-reference to evidence F (backoffice):** E7/E9 are F13/F14 from the patient side. F’s F11 state chain `created → pharmacy_selected → order_placed → dispensed` is **not supported by the recovered client contract**: the client exposes `state` plus cancel/switch flags and no dispense/ack feed; whether a server-side dispense feed exists is Unknown `[CODE lib/store/api/pharmacyOrderApi.ts:15-24]`. F13’s “checklist gates refills on questionnaire + labs + visit” should be qualified: the model supports those types, but the GLP-1 criteria set is server-side and unobserved.
- **Handoff to Main (tech plan):** the highest-leverage missing integrations are (1) a pharmacy dispense/ack feed, (2) a dose/adherence event, (3) a weight/vitals capture or device sync, (4) a PA status webhook, and (5) an after-hours symptom-triage path. None exists in the recovered client.
- **Handoff to Main (operating plan):** staff the *fulfillment* queue (pharmacy transmission failures, PA, out-of-stock) at least as heavily as the *clinical* review queue; the 1★ tail is fulfillment, not diagnosis `[DOC adversarial-and-market-report.md §3.6]`.
